{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:40:52Z","timestamp":1793630452361,"version":"4.5.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH62873"],"award-info":[{"award-number":["R01MH62873"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Organization for Scientific Research","award":["1750102007010"],"award-info":[{"award-number":["1750102007010"]}]},{"DOI":"10.13039\/501100001826","name":"Netherlands organization for Health Research and Development","doi-asserted-by":"crossref","award":["113202005"],"award-info":[{"award-number":["113202005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00787-019-01283-y","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T08:22:48Z","timestamp":1549354968000},"page":"1213-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit\/hyperactivity disorder"],"prefix":"10.1007","volume":"28","author":[{"given":"Annabeth P.","family":"Groenman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizanne J. S.","family":"Schweren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Weeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Luman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri D. S.","family":"Noordermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Heslenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen V.","family":"Faraone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda","family":"Rommelse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina A.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Oosterlaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"issue":"3","key":"1283_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cpr.2011.01.006","volume":"31","author":"SS Lee","year":"2011","unstructured":"Lee SS, Humphreys KL, Flory K, Liu R, Glass K (2011) Prospective association of childhood attention-deficit\/hyperactivity disorder (ADHD) and substance use and abuse\/dependence: a meta-analytic review. Clin Psychol Rev 31(3):328\u2013341. \n                    https:\/\/doi.org\/10.1016\/j.cpr.2011.01.006","journal-title":"Clin Psychol Rev"},{"key":"1283_CR2","unstructured":"National Institute for Health and Clinical Excellence (2000) Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit\/hyperactivity disorder (ADHD) in Childhood, vol 13. NICE"},{"issue":"2","key":"1283_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11539440-000000000-00000","volume":"25","author":"X Castells","year":"2011","unstructured":"Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M (2011) Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 25(2):157\u2013169. \n                    https:\/\/doi.org\/10.2165\/11539440-000000000-00000","journal-title":"CNS Drugs"},{"issue":"4","key":"1283_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","volume":"19","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Buitelaar J (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19(4):353\u2013364. \n                    https:\/\/doi.org\/10.1007\/s00787-009-0054-3","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"1283_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1542\/peds.2014-0179","volume":"133","author":"EN Schoenfelder","year":"2014","unstructured":"Schoenfelder EN, Faraone SV, Kollins SH (2014) Stimulant treatment of ADHD and cigarette smoking: a meta-analysis. Pediatrics 133(6):1070\u20131080. \n                    https:\/\/doi.org\/10.1542\/peds.2014-0179","journal-title":"Pediatrics"},{"issue":"7","key":"1283_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamapsychiatry.2013.1273","volume":"70","author":"KL Humphreys","year":"2013","unstructured":"Humphreys KL, Eng T, Lee SS (2013) Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry 70(7):740\u2013749. \n                    https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.1273","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"1283_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","volume":"165","author":"S Mannuzza","year":"2008","unstructured":"Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH, Castellanos FX (2008) Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165(5):604\u2013609. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.2008.07091465","journal-title":"Am J Psychiatry"},{"key":"1283_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/add.12188","author":"AP Groenman","year":"2013","unstructured":"Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV (2013) Substance use disorders in adolescents with attention deficit hyperactivity disorder: a four-year follow-up study. Addiction (Abingdon, England). \n                    https:\/\/doi.org\/10.1111\/add.12188","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"1283_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.addbeh.2013.09.002","volume":"39","author":"S Dalsgaard","year":"2014","unstructured":"Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH (2014) ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood\u2014a naturalistic long-term follow-up study. Addict Behav 39(1):325\u2013328. \n                    https:\/\/doi.org\/10.1016\/j.addbeh.2013.09.002","journal-title":"Addict Behav"},{"issue":"2","key":"1283_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.euroneuro.2013.11.003","volume":"24","author":"HC Steinhausen","year":"2014","unstructured":"Steinhausen HC, Bisgaard C (2014) Substance use disorders in association with attention-deficit\/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample. Eur Neuropsychopharmacol 24(2):232\u2013241. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.003","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"1283_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/archpedi.162.10.916","volume":"162","author":"TE Wilens","year":"2008","unstructured":"Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J (2008) Effect of prior stimulant treatment for attention-deficit\/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 162(10):916\u2013921","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"1283_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jaac.2012.12.014","volume":"52","author":"BS Molina","year":"2013","unstructured":"Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S (2013) Adolescent substance use in the multimodal treatment study of attention-deficit\/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry 52(3):250\u2013263. \n                    https:\/\/doi.org\/10.1016\/j.jaac.2012.12.014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"1283_CR13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.neubiorev.2011.02.011","volume":"35","author":"EM Marco","year":"2011","unstructured":"Marco EM, Adriani W, Ruocco LA, Canese R, Sadile AG, Laviola G (2011) Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure. Neurosci Biobehav Rev 35(8):1722\u20131739. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2011.02.011","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1283_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaac.2016.03.011","volume":"55","author":"SE McCabe","year":"2016","unstructured":"McCabe SE, Dickinson K, West BT, Wilens TE (2016) Age of onset, duration, and type of medication therapy for attention-deficit\/hyperactivity disorder and substance use during adolescence: a multi-cohort national study. J Am Acad Child Adolesc Psychiatry 55(6):479\u2013486. \n                    https:\/\/doi.org\/10.1016\/j.jaac.2016.03.011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"1283_CR15","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.4088\/JCP.15m10624","volume":"78","author":"LJS Schweren","year":"2017","unstructured":"Schweren LJS, Groenman AP, von Rhein D, Weeda W, Luman M, Faraone SV, Heslenfeld D, Franke B, Buitelaar J, Oosterlaan J, Hoekstra PJ, Hartman CA (2017) Stimulant treatment trajectories are associated with neural reward processing in attention-deficit\/hyperactivity disorder. J Clin Psychiatry 78(7):e790\u2013e796. \n                    https:\/\/doi.org\/10.4088\/JCP.15m10624","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1283_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1192\/bjp.bp.112.124784","volume":"203","author":"AP Groenman","year":"2013","unstructured":"Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV (2013) Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry 203(2):112\u2013119. \n                    https:\/\/doi.org\/10.1192\/bjp.bp.112.124784","journal-title":"Br J Psychiatry"},{"issue":"10","key":"1283_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.mp.4001869","volume":"11","author":"K Brookes","year":"2006","unstructured":"Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Aneey R, Franke B, Gill M, Ebstein R (2006) The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11(10):934\u2013953","journal-title":"Mol Psychiatry"},{"key":"1283_CR18","volume-title":"Diagnostic and statistical manual of mental disorders [DSM-IV-TR]","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. American Psychiatric Association, Washington, DC"},{"key":"1283_CR19","volume-title":"Generalized additive models","author":"TJ Hastie","year":"1990","unstructured":"Hastie TJ, Tibshirani RJ (1990) Generalized additive models, vol 43. CRC Press, Boca Raton"},{"key":"1283_CR20","doi-asserted-by":"publisher","DOI":"10.1201\/9781420010404","volume-title":"Generalized additive models: an introduction with R","author":"S Wood","year":"2006","unstructured":"Wood S (2006) Generalized additive models: an introduction with R. CRC Press, Boca Raton"},{"key":"1283_CR21","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"10","author":"VD Blondel","year":"2008","unstructured":"Blondel VD, Guillaume J-L, Lambiotte R (2008) Lefebvre E (2008) Fast unfolding of communities in large networks. J Stat Mech 10:P10008","journal-title":"J Stat Mech"},{"issue":"4","key":"1283_CR22","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.neuroimage.2011.03.069","volume":"56","author":"M Rubinov","year":"2011","unstructured":"Rubinov M, Sporns O (2011) Weight-conserving characterization of complex functional brain networks. Neuroimage 56(4):2068\u20132079","journal-title":"Neuroimage"},{"issue":"17","key":"1283_CR23","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1073\/pnas.1115365109","volume":"109","author":"DA Fair","year":"2012","unstructured":"Fair DA, Bathula D, Nikolas MA, Nigg JT (2012) Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc Natl Acad Sci 109(17):6769\u20136774","journal-title":"Proc Natl Acad Sci"},{"key":"1283_CR24","unstructured":"Huber PJ (1967) The behavior of maximum likelihood estimates under non-standard conditions. In: the Fifth Berkeley Symposium on Mathematical Statistics and Probability, pp 221\u2013233"},{"issue":"5","key":"1283_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1089\/cap.2005.15.764","volume":"15","author":"SK Katusic","year":"2005","unstructured":"Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ (2005) Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit\/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 15(5):764\u2013776. \n                    https:\/\/doi.org\/10.1089\/cap.2005.15.764","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"1283_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004583-199701000-00013","volume":"36","author":"J Biederman","year":"1997","unstructured":"Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J (1997) Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36(1):21\u201329. \n                    https:\/\/doi.org\/10.1097\/00004583-199701000-00013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"1283_CR27","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1017\/S0033291707000335","volume":"37","author":"SV Faraone","year":"2007","unstructured":"Faraone SV, Biederman J, Wilens TE, Adamson J (2007) A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med 37(12):1743\u20131752. \n                    https:\/\/doi.org\/10.1017\/s0033291707000335","journal-title":"Psychol Med"},{"issue":"5","key":"1283_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","volume":"165","author":"J Biederman","year":"2008","unstructured":"Biederman J, Monuteaux MC, Spencer T, Wilens TE, MacPherson HA, Faraone SV (2008) Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 165(5):597\u2013603","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1283_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12402-012-0078-2","volume":"4","author":"K Moshe","year":"2012","unstructured":"Moshe K, Karni A, Tirosh E (2012) Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial. Atten Defic Hyperact Disord 4(3):153\u2013158","journal-title":"Atten Defic Hyperact Disord"},{"issue":"2","key":"1283_CR30","doi-asserted-by":"publisher","first-page":"e0116407","DOI":"10.1371\/journal.pone.0116407","volume":"10","author":"LE Arnold","year":"2015","unstructured":"Arnold LE, Hodgkins P, Caci H, Kahle J, Young S (2015) Effect of treatment modality on long-term outcomes in attention-deficit\/hyperactivity disorder: a systematic review. PLoS One 10(2):e0116407. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0116407","journal-title":"PLoS One"},{"key":"1283_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1741-7015-10-99","volume":"10","author":"M Shaw","year":"2012","unstructured":"Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE (2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 10:99. \n                    https:\/\/doi.org\/10.1186\/1741-7015-10-99","journal-title":"BMC Med"},{"key":"1283_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/1087054713486516","author":"V Harpin","year":"2013","unstructured":"Harpin V, Mazzone L, Raynaud JP, Kahle J, Hodgkins P (2013) Long-term outcomes of ADHD: A systematic review of self-esteem and social function. J Atten Disord. \n                    https:\/\/doi.org\/10.1177\/1087054713486516","journal-title":"J Atten Disord"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-019-01283-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-019-01283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-019-01283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:12:08Z","timestamp":1580843528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-019-01283-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s00787-019-01283-y","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"27 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the past year, Dr. Faraone received income, potential income, reimbursement for travel expenses and\/or research support from Pfizer, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA Pharma, Neurovance, Impax and NeuroLifeSciences. In previous years, he received income or research support from: Shire, Alcobra, Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. Dr. Faraone receives royalties from books published by Guilford Press: <i>Straight Talk about Your Child\u2019s Mental Health<\/i>, Oxford University Press: <i>Schizophrenia: The Facts<\/i> and Elsevier, <i>ADHD: Non<\/i>-<i>Pharmacologic Interventions<\/i>. Dr. Hoekstra reports grants and personal fees from Shire, outside the submitted work; Dr. Buitelaar reports personal fees from Lilly, Janssen Cilag, Lundbeck, Shire and Servier, all outside the submitted work; Dr. Oosterlaan reports grants from Shire pharmaceuticals, outside the submitted work. The other authors have no financial relationships relevant to this work to disclose. Dr. Faraone, with his institution, he has US patent US20130217707 A1 for the use of sodium\u2013hydrogen exchange inhibitors in the treatment of ADHD. The other authors have no potential conflicts of interest relevant to this work to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}